Loading company…
Halifax-based developer of rapid diagnostic tests that deliver instant results, including the FDA-approved Reveal G4 HIV test.
MedMira develops rapid diagnostic tests, including the FDA-approved Reveal G4, which gives instant HIV results, and the Multiplo multiplex tests for HIV-1/2, Hepatitis B and C, and Syphilis. Its Miriad toolkit supports the development of new diagnostic tests. Founded by Hermes Chan and headquartered in Halifax, Canada, the company has received a total of CAD 0.500 mn in funding across four deals, and following an acquisition by Consilium Partners, its listed stage is Public.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in